HK1101580A1 - Diastereoselective synthesis process for the preapration of imidazole compounds - Google Patents

Diastereoselective synthesis process for the preapration of imidazole compounds

Info

Publication number
HK1101580A1
HK1101580A1 HK07109363.3A HK07109363A HK1101580A1 HK 1101580 A1 HK1101580 A1 HK 1101580A1 HK 07109363 A HK07109363 A HK 07109363A HK 1101580 A1 HK1101580 A1 HK 1101580A1
Authority
HK
Hong Kong
Prior art keywords
methyl
synthesis process
preapration
sub
imidazole compounds
Prior art date
Application number
HK07109363.3A
Other languages
English (en)
Inventor
Walter Ferdinand Maria Filliers
Rudy Laurent Maria Broeckx
Patrick Rene Angibaud
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1101580A1 publication Critical patent/HK1101580A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK07109363.3A 2004-05-03 2007-08-28 Diastereoselective synthesis process for the preapration of imidazole compounds HK1101580A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04076319 2004-05-03
PCT/EP2005/051934 WO2005105784A1 (en) 2004-05-03 2005-04-28 Diastereoselective synthesis process for the preparation of imidazole compounds

Publications (1)

Publication Number Publication Date
HK1101580A1 true HK1101580A1 (en) 2007-10-18

Family

ID=34966069

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109363.3A HK1101580A1 (en) 2004-05-03 2007-08-28 Diastereoselective synthesis process for the preapration of imidazole compounds

Country Status (11)

Country Link
US (1) US7456287B2 (xx)
EP (1) EP1751137B1 (xx)
JP (1) JP5008554B2 (xx)
CN (1) CN100567292C (xx)
AT (1) ATE397600T1 (xx)
AU (1) AU2005238223B2 (xx)
CA (1) CA2563807C (xx)
DE (1) DE602005007346D1 (xx)
ES (1) ES2308486T3 (xx)
HK (1) HK1101580A1 (xx)
WO (1) WO2005105784A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2985123C (en) 2015-08-17 2021-04-13 Antonio Gualberto Methods of treating cancer patients with farnesyltransferase inhibitors
MY190861A (en) 2016-11-03 2022-05-12 Kura Oncology Inc Farnesyltransferase inhibitors for use in methods of treating cancer
CN110234639A (zh) * 2016-12-08 2019-09-13 杭州领业医药科技有限公司 替吡法尼的晶型及其制备方法及药物组合物
CA3100706A1 (en) 2018-05-18 2019-11-21 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69620445T2 (de) 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
HN2000000266A (es) * 2000-01-21 2001-05-21 Pfizer Prod Inc Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
AU2002253101B2 (en) * 2001-03-12 2007-08-09 Janssen Pharmaceutica N.V. Process for the preparation of imidazole compounds
AU2003241747A1 (en) * 2002-06-11 2003-12-22 Kaneka Corporation PROCESS FOR PRODUCING OPTICALLY ACTIVE ss-AMINO ALCOHOL

Also Published As

Publication number Publication date
CN100567292C (zh) 2009-12-09
ES2308486T3 (es) 2008-12-01
DE602005007346D1 (de) 2008-07-17
CA2563807C (en) 2012-11-20
EP1751137A1 (en) 2007-02-14
US20070238880A1 (en) 2007-10-11
AU2005238223A1 (en) 2005-11-10
CN1946711A (zh) 2007-04-11
WO2005105784A1 (en) 2005-11-10
EP1751137B1 (en) 2008-06-04
JP2007536335A (ja) 2007-12-13
US7456287B2 (en) 2008-11-25
CA2563807A1 (en) 2005-11-10
JP5008554B2 (ja) 2012-08-22
ATE397600T1 (de) 2008-06-15
AU2005238223B2 (en) 2012-04-26

Similar Documents

Publication Publication Date Title
DK1713475T3 (da) 1,3,5-trisubstituerede 4,5-dihydro-1H-pyrazol-derivater med CB1-antagonistisk aktivitet
RS54030B1 (en) PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT
WO2008065626A3 (en) 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors
WO2005070890A3 (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
NZ591449A (en) Picolinamide derivatives as kinase inhibitors
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
SI1651040T1 (sl) Fungicidne kombinacije ternarnih aktivnih snovi
WO2010131922A4 (en) Amide compound, preparation method thereof and pharmaceutical composition comprising same
CA2683059A1 (en) Atropisomer of pyrrole derivative
WO2008096231A8 (en) Antiparasitic agents
RS50574B (sr) (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
WO2008032338A3 (en) Improved process for the preparation of ezetimibe and its intermediates
HK1101580A1 (en) Diastereoselective synthesis process for the preapration of imidazole compounds
WO2006023659A3 (en) Novel polymorphs of azabicyclohexane
EA201100696A1 (ru) 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6
WO2008014360A3 (en) Modulators of chemokine receptor activity, crystalline forms and process
HRP20030695B1 (en) Process for the preparation of imidazole compounds
JP2017502063A5 (xx)
HK1101326A1 (en) Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
WO2006023395A3 (en) 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
HK1101398A1 (en) Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2- methoxy-quinoline
MA31206B1 (fr) Dérivés cyclohexyl amide d'acide carboxylique aryle
MX2010002585A (es) Derivados de piperidina como antagonistas del receptor nk3.
MX2007012386A (es) 7-fluoro-1,3-dihidro-indol-2-ona oxazolidinonas como agentes antibacterianos.